Now Playing:(GMCR, STEM, DSCO) CRWENewswire Stocks In Action
Description:
StemCells Inc - STEM - reported that the FDA has authorized the
initiation of a Phase I/II clinical trial of the Company’s
proprietary HuCNS-SC product candidate (purified human neural stem
cells) in dry age-related ...